OTC Pharmaceuticals - Chad

  • Chad
  • Revenue in the OTC Pharmaceuticals market amounts to US$42.65m in 2024. The market is expected to grow annually by 8.14% (CAGR 2024-2029).
  • The market's largest segment is the segment Vitamins & Minerals with a market volume of US$15.43m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$2.26 are generated in 2024.
  • In the OTC Pharmaceuticals market, 1.1% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Chad is experiencing significant growth and development.

Customer preferences:
In Chad, there is a growing demand for over-the-counter (OTC) pharmaceutical products. Customers in the country are increasingly seeking access to affordable and readily available medications without the need for a prescription. This preference for OTC products is driven by several factors, including convenience, cost-effectiveness, and a desire for self-care.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Chad is the increasing availability and variety of OTC products. Pharmaceutical companies are expanding their product portfolios to cater to the specific needs and preferences of customers in Chad. This includes a wide range of OTC medications for common ailments such as cold and flu, pain relief, digestive issues, and allergies. Another trend in the market is the growing popularity of herbal and natural remedies. Chad has a rich tradition of using traditional medicine, and many customers are turning to herbal remedies for various health conditions. As a result, pharmaceutical companies are introducing herbal and natural OTC products to meet this demand.

Local special circumstances:
Chad is a landlocked country with limited access to healthcare facilities, especially in rural areas. This has led to a reliance on OTC medications for self-care and treatment of minor ailments. The availability of OTC products allows individuals to manage their health without having to travel long distances or wait for medical consultations. Furthermore, the high cost of prescription medications and the limited availability of healthcare professionals contribute to the preference for OTC products. Many individuals in Chad do not have health insurance or access to government-funded healthcare, making OTC medications a more affordable option.

Underlying macroeconomic factors:
The development of the OTC Pharmaceuticals market in Chad is also influenced by underlying macroeconomic factors. The country has been experiencing steady economic growth in recent years, which has led to an increase in disposable income. As a result, individuals have more purchasing power and are able to afford OTC medications. Additionally, the government of Chad has implemented policies to promote the development of the healthcare sector, including the availability of OTC medications. This includes initiatives to improve the regulatory framework for OTC products and promote public awareness of the benefits of self-care. In conclusion, the OTC Pharmaceuticals market in Chad is growing and developing due to customer preferences for convenience and affordability, the availability of a wide range of OTC products, the popularity of herbal remedies, limited access to healthcare facilities, high cost of prescription medications, and underlying macroeconomic factors such as economic growth and government initiatives.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)